Research Compounds
Every compound is independently tested, verified for purity, and shipped from the United States.
A pentadecapeptide studied for its interaction with pathways associated with tissue recovery, cellular repair, and structural integrity.
A synthetic analog of Thymosin Beta-4, studied for its role in cellular migration, tissue repair signaling, and structural resilience.
A copper-binding peptide studied for its role in cellular signaling pathways associated with tissue remodeling and regenerative research.
A next-generation metabolic peptide with triple-receptor activity, studied for advanced body composition and metabolic acceleration research.
A dual-receptor peptide studied for its interaction with GLP-1 and GIP pathways involved in appetite regulation and metabolic signaling.
A research compound studied for its interaction with NNMT enzyme pathways associated with metabolic efficiency and body composition.
Peptides studied for their interaction with growth hormone signaling pathways, commonly explored together for recovery and sleep support.
A short tripeptide studied for its interaction with inflammatory signaling pathways, gut integrity, and immune system modulation.
A mitochondrial-derived peptide studied for its role in cellular energy regulation and metabolic signaling in performance research.
A peptide studied for its role in neurochemical signaling pathways associated with cognitive function, focus, and clarity.
A peptide studied for its relationship with neurotransmitter balance and neurochemical signaling in mood regulation and stress response.
A coenzyme studied for its role in cellular energy production and mitochondrial signaling pathways in metabolic and longevity research.
A synthetic analog of growth hormone-releasing hormone (GHRH) studied for its role in stimulating natural growth hormone production.
A long-acting amylin receptor agonist studied for appetite regulation and metabolic signaling pathways.
A modified fragment of human growth hormone (HGH 176-191) studied for fat metabolism without affecting blood sugar or growth.
A modified GHRH analog without Drug Affinity Complex, studied for pulsatile growth hormone release patterns.
A selective growth hormone releasing peptide studied for GH stimulation with minimal impact on cortisol and prolactin.
A mitochondrial-targeted peptide studied for cellular energy optimization and oxidative stress reduction.
A melanocortin receptor agonist studied for its effects on central nervous system pathways related to arousal and desire.
A neuropeptide studied for its role in sleep architecture, stress response, and neuroendocrine regulation.
A modified form of IGF-1 with extended half-life, studied for cell proliferation and tissue growth signaling.
A naturally occurring thymic peptide studied for immune system modulation and T-cell maturation pathways.
Quality Assurance
All ClarityLabs compounds undergo independent third-party testing before distribution. COAs available on request.
View Testing Standards